High materiality7/10
Ionis Pharmaceuticals price target lowered to $56 from $69 at Goldman Sachs
Why it may matterVerify against the original reporting
bearish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Goldman Sachs lowers IONS target to $56 from $69. Current price $58.09; target below price; price change since signal -2.35.
- Target $56; Price $58.09; Change -2.35
Key facts
- 01
Target: $56
- 02
Posted price: $58.09
- 03
Analyst firm: Goldman Sachs
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.